RATIONALE: It remains unclear how gastroesophageal reflux disease (GERD) affects allograft microbial community composition in lung transplant recipients, and its impact on lung allograft inflammation and function. OBJECTIVES: Our objective was to compare the allograft microbiota in lung transplant recipients with or without clinically diagnosed GERD in the first post-transplant year, and assess associations between GERD, allograft microbiota, inflammation and acute and chronic lung allograft dysfunction (ALAD/CLAD). METHODS: 268 bronchoalveolar lavage samples were collected from 75 lung transplant recipients at a single transplant centre every 3 months post-transplant for 1 year. Ten transplant recipients from a separate transplant centre p...
Background: Lung transplant patients experience a high risk of airway infections and microbial colon...
Abstract Background Chronic Lung Allograft Dysfunction (CLAD) is the main cause of morbidity and mor...
AbstractObjectives: Bronchiolitis obliterans is the greatest limitation to the long-term applicabili...
Abstract Whether the alternated microbiota in the gut contribute to the risk of allograft rejection ...
BACKGROUND: Lung transplant (LTx) recipients are at increased risk for airway infections, but the ca...
Background: Lung transplantation (LT) is a recognized treatment for end-stage pulmonary disease. Bac...
RATIONALE In lung transplant recipients, long-term graft survival relies on the control of inflamma...
In lung transplant recipients, long-term graft survival relies on the control of inflammation and ti...
Rationale: Long-term survival after lung transplantation is limited by infectious complications and ...
Background: Lung transplantation (LT) is a recognized treatment for end-stage pulmonary disease. Bac...
BACKGROUND: Alterations in the lung microbiota may drive disease development and progression in pati...
BACKGROUND: Alterations in the lung microbiota may drive disease development and progression in pati...
There is accumulating evidence that the lower airway microbiota impacts lung health. However, the li...
We assessed the gut microbiome in 64 faecal samples from end-stage lung disease patients before tran...
Introduction: Use of bronchoalveolar lavage fluid (BALF) for analysis of the allograft microbiota in...
Background: Lung transplant patients experience a high risk of airway infections and microbial colon...
Abstract Background Chronic Lung Allograft Dysfunction (CLAD) is the main cause of morbidity and mor...
AbstractObjectives: Bronchiolitis obliterans is the greatest limitation to the long-term applicabili...
Abstract Whether the alternated microbiota in the gut contribute to the risk of allograft rejection ...
BACKGROUND: Lung transplant (LTx) recipients are at increased risk for airway infections, but the ca...
Background: Lung transplantation (LT) is a recognized treatment for end-stage pulmonary disease. Bac...
RATIONALE In lung transplant recipients, long-term graft survival relies on the control of inflamma...
In lung transplant recipients, long-term graft survival relies on the control of inflammation and ti...
Rationale: Long-term survival after lung transplantation is limited by infectious complications and ...
Background: Lung transplantation (LT) is a recognized treatment for end-stage pulmonary disease. Bac...
BACKGROUND: Alterations in the lung microbiota may drive disease development and progression in pati...
BACKGROUND: Alterations in the lung microbiota may drive disease development and progression in pati...
There is accumulating evidence that the lower airway microbiota impacts lung health. However, the li...
We assessed the gut microbiome in 64 faecal samples from end-stage lung disease patients before tran...
Introduction: Use of bronchoalveolar lavage fluid (BALF) for analysis of the allograft microbiota in...
Background: Lung transplant patients experience a high risk of airway infections and microbial colon...
Abstract Background Chronic Lung Allograft Dysfunction (CLAD) is the main cause of morbidity and mor...
AbstractObjectives: Bronchiolitis obliterans is the greatest limitation to the long-term applicabili...